Cargando…
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
There are conflicting reports on the adverse effects of erythropoietin (EPO) for the management of cancer-associated anemia. The recognition that erythropoietin receptors (EPORs) are expressed outside the erythroid lineage and concerns that erythropoiesis-stimulating agents (ESAs) may cause tumors t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325163/ https://www.ncbi.nlm.nih.gov/pubmed/30622244 http://dx.doi.org/10.1038/s41419-018-1274-6 |